Echo Protocol will stop operating after November 14, ending new deposits, borrowing, and interest accrual in its lending service. Users can still repay loans, withdraw assets, and unstake until 6:59 p.m. ET on November 19. The protocol is winding down after nearly two years, with liquidation of overdue loans and a final settlement period. Echo also warns users to ignore suspicious fund transfer requests and will keep its Aptos-to-B² Network bridge open for redemptions after other services close.
Echo Protocol's cessation of operations is the focus here, with Pluang market data providing context as of Oct 20, 2026 02:41 WIB: Among 50 major cryptocurrencies priced on Pluang, 43 rose and 6 fell today. Notable movers include DOT (Polkadot) at Rp20.506 with a 7.19% increase and 83% sell order activity, ATOM (Cosmos) at Rp31.331 up 5.26% with 76% buy order activity, and UNI (Uniswap) at Rp129.875 rising 4.40% with 66% buy order activity.
XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...
XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...
Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
